Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (27944)	2/6/1999 8:53:00 PM
From: RXGOLF	Read Replies (2) \| Respond to of 32384

OK, OK, OK, now I am with you on the off label use thoughts, but I still love the possibility of what may happen with ONTAK in that area! Obviously, getting a fast track approval is the quickest way to get a drug to market and ring the register. Also, while the drug is being sold, further trials of efficacy and safety can be ongoing and might very well expand the market of said drug. I have often seen drugs come out years after introduction with added approved indications. The reps love it! Greg